Stock listing
NASDAQ:FUSN Fusion Pharmaceuticals Inc Stock
Follow Fusion Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:FUSN
$21.55 USD
Close on Jun 3, 2024 · No longer trades
- Lowest – highest close
- $1.98 – $21.55 USDSince Jun 26, 2020 · lowest Nov 7, 2022 · highest Jun 3, 2024
Delisted NASDAQ:FUSN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:FUSN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Fusion Pharmaceuticals Inc on 6ix
- Decks
- 7 decks · latest Mar 19, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (March 2024) | Merger or acquisition | 24 slides | Mar 19, 2024 |
| Investor Presentation (January 2024) | Investor deck | 26 slides | Jan 4, 2024 |
| Technical Presentation (June 2023) | Technical | 23 slides | Jun 27, 2023 |
| Merger or Acquisition (February 2023) | Merger or acquisition | 27 slides | Feb 13, 2023 |
| Investor Presentation (June 2022) | Investor deck | 33 slides | Jun 9, 2022 |
| Corporate Update (March 2021) | Corporate update | 12 slides | Mar 2, 2021 |
| Merger or Acquisition (November 2020) | Merger or acquisition | 26 slides | Nov 2, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Barbara Duncan Other companies: Halozyme Therapeutics, Inc. (Director · Since at least Feb 3, 2023); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); Ovid Therapeutics Inc. (Director, Chair of the Audit Committee, Member of the Nominating and Corporate Governance Committee · Since at least Jun 14, 2017); Immunomedics Inc (Director · Mar 5, 2019 – Oct 23, 2020 · Past); Jounce Therapeutics Inc (Director · Jan 26, 2017 – May 3, 2023 · Past); Innoviva, Inc. (Director · Nov 18, 2016 – Apr 20, 2017 · Past); Adaptimmune Therapeutics PLC (Director · Jun 23, 2016 – Jul 1, 2022 · Past); Aevi Genomic Medicine LLC (Director · Jul 22, 2015 – Feb 3, 2020 · Past); Intercept Pharmaceuticals Inc (Chief Accounting Officer · Oct 10, 2012 – Oct 3, 2016 · Past) | Director · Oct 30, 2020 – Jun 4, 2024 · Past |
| Chau Quang Khuong Other companies: Damora Therapeutics, Inc. (Director · Oct 28, 2020 – Jun 14, 2023 · Past); NextCure, Inc. (Director · May 8, 2019 – Jun 22, 2023 · Past); Inspire Medical Systems, Inc. (Director · May 2, 2018 – Oct 9, 2020 · Past); Synlogic Inc (Director · Aug 28, 2017 – Apr 20, 2021 · Past); Whitehawk Therapeutics, Inc. (Director · Mar 15, 2017 – Jun 18, 2019 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Jun 23, 2017 · Past); Palvella Therapeutics, Inc. (Director · Jun 29, 2015 – Oct 25, 2017 · Past); Otonomy Inc (Director · Aug 12, 2014 – Jun 21, 2016 · Past) | Director · Jun 25, 2020 – Jun 14, 2023 · Past |
| Heather Preston Other companies: Oxford Nanopore Technologies PLC (Non Executive Director · Since at least May 1, 2026); Aligos Therapeutics, Inc. (Director · Since at least Aug 7, 2024); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Jun 24, 2021 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jun 19, 2019 · Past); Albireo Pharma Inc (Director · Nov 3, 2016 – Jan 23, 2017 · Past); Otonomy Inc (Director · Aug 12, 2014 – Jun 11, 2019 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – Oct 22, 2019 · Past) | Director · Jun 25, 2020 – Jun 14, 2023 · Past |
| Pablo J. Cagnoni Other companies: Incyte Corporation (President, Incyte and Global Head of R&D · Since at least Jun 5, 2023); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – Feb 1, 2023 · Past); CRISPR Therapeutics AG (Director · Oct 18, 2016 – Nov 19, 2019 · Past); Onyx Pharmaceuticals Inc (EVP, Global R&D and Tech Ops · Mar 11, 2013 – Oct 1, 2013 · Past); Allos Therapeutics Inc (Sr. VP, Chief Medical Officer · Mar 19, 2007 – Sep 30, 2009 · Past); Osi Pharmaceuticals Inc (VP & Chief Medical Officer · Dec 13, 2006 – Dec 13, 2006 · Past) | Director · Jun 25, 2020 – Jun 4, 2024 · Past |
| David Meek Other companies: Cullinan Therapeutics, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least May 15, 2024); uniQure N.V. (Chairman of the Board · Since at least Jun 13, 2018); Entasis Therapeutics Holdings Inc (Director · Jun 19, 2019 – Jul 7, 2022 · Past); Baxalta Inc (EVP and President, Oncology · Jun 30, 2015 – Jun 3, 2016 · Past); Endocyte Inc (Chief Commercial Officer · Aug 3, 2012 – Feb 6, 2014 · Past) | Director · Oct 16, 2023 – Jun 4, 2024 · Past |
| Jeremy Bender Other companies: Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); Aura Biosciences, Inc. (Director · Since at least Jul 7, 2026); Mereo BioPharma Group plc (Non-Executive Director · Since at least Jan 1, 2024); Day One Biopharmaceuticals Inc (CHIEF EXECUTIVE OFFICER, Director · Since at least May 26, 2021) | Director · Oct 16, 2023 – Jun 4, 2024 · Past |
| Donald A Bergstrom Other companies: Relay Therapeutics, Inc. (President, R&D · Since at least Jul 15, 2020); Mersana Therapeutics Inc (Chief Medical Officer · Jun 27, 2017 – Feb 2, 2018 · Past) | Director · Apr 1, 2021 – Jun 4, 2024 · Past |
| John J Crowley Other companies: Centessa Pharmaceuticals PLC (Chief Financial Officer · Since at least Jun 10, 2024); Charles River Laboratories International, Inc. (SVP, Chief Accounting Officer · May 24, 2016 – Oct 1, 2016 · Past) | Chief Financial Officer · Jun 25, 2020 – Jun 4, 2024 · Past |
| Philina Lee Other companies: DBV Technologies SA (Board Member · Since at least Oct 30, 2025); Blueprint Medicines Corp (Chief Commercial Officer · Since at least Apr 4, 2022) | Director · Feb 11, 2021 – Jun 4, 2024 · Past |
| Teresa Bitetti Other companies: Takeda Pharmaceutical Co. Ltd. (President, Global Oncology Business Unit · Since at least Jan 5, 2026); Aura Biosciences, Inc. (Director · Since at least Mar 31, 2025) | Director · Oct 16, 2023 – Jun 4, 2024 · Past |
All 19 people
| Person | Seat |
|---|---|
| Christopher P Leamon Other companies: Endocyte Inc (Vice President of Research · Dec 21, 2011 – Dec 21, 2018 · Past) | Chief Scientific Officer · Nov 1, 2021 – Jun 4, 2024 · Past |
| James J O'Leary Other companies: ImmunoGen Inc (Vice President · Nov 7, 2008 – Jul 17, 2014 · Past) | Chief Medical Officer · Jun 25, 2020 – Feb 1, 2022 · Past |
| Johan Christenson Other companies: Aprea Therapeutics, Inc. (Director · Oct 2, 2019 – Jun 30, 2020 · Past) | Director · Jun 25, 2020 – Jun 30, 2020 · Past |
| Steven Gannon Other companies: Xenon Pharmaceuticals Inc. (Director · Since at least May 21, 2015) | Director · Jun 25, 2020 – Jun 4, 2024 · Past |
| Damian Lamb | Director · Jun 25, 2020 – Jun 25, 2020 · Past |
| Dmitri Bobilev | Chief Medical Officer · Nov 7, 2022 – Jun 4, 2024 · Past |
| Eric Burak | Chief Technology Officer · Jun 25, 2020 – Jun 4, 2024 · Past |
| John Valliant | Chief Executive Officer, Director · Jun 25, 2020 – Jun 4, 2024 · Past |
| Mohit Rawat | President & CBO · Sep 27, 2021 – Jun 4, 2024 · Past |
Log in to ask 6ix AI your own questions about Fusion Pharmaceuticals Inc.